<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="peripheral tolerance maintained by mast cell IL-5 suppresses oxazolone-induced contact" exact="hypersensitivity" post="http://orcid.org/0000-0002-0566-0142 Kim Hyuk Soon 1 * http://orcid.org/0000-0002-6873-1518 Lee Min"/>
 <result pre="in an IL-10–dependent manner in mice with oxazolone-induced severe contact" exact="hypersensitivity" post="(CHS). Mast cell (MC) IL-5 was important for maintaining"/>
 <result pre="2 ) were the first to demonstrate that the delayed-type" exact="hypersensitivity" post="reaction was aggravated by the depletion of B cells."/>
 <result pre="immune disorders, such as collagen-induced arthritis, experimental autoimmune encephalomyelitis, contact" exact="hypersensitivity" post="(CHS), and colitis ( 4 ). Although the inhibitory"/>
 <result pre="as collagen-induced arthritis, experimental autoimmune encephalomyelitis, contact hypersensitivity (CHS), and" exact="colitis" post="( 4 ). Although the inhibitory mechanism of B"/>
 <result pre="the population of T reg cells to inhibit experimental autoimmune" exact="uveitis" post="( 4 ). The knockout of IL-35 in B"/>
 <result pre="limited. Mast cells (MCs) are essential cells for inducing immediate" exact="hypersensitivity" post="(also known as type I hypersensitivity) through immunoglobulin E"/>
 <result pre="various stimulants in the state of allergic diseases, such as" exact="atopic dermatitis," post="allergic rhinitis, asthma, and anaphylaxis, thereby increasing the severity"/>
 <result pre="in the state of allergic diseases, such as atopic dermatitis," exact="allergic rhinitis," post="asthma, and anaphylaxis, thereby increasing the severity of the"/>
 <result pre="vivo ( 9 , 10 ). In the type I" exact="hypersensitivity" post="immune response, the CD40 ligand of MCs stimulates B"/>
 <result pre="chronic allergic inflammatory responses similar to those observed in human" exact="atopic dermatitis," post="such as barrier disruption, T H2 cell–predominant inflammation, and"/>
 <result pre="also play a critical role in causing allergic symptoms in" exact="atopic dermatitis" post="and allergic asthma ( 18 ). In particular, IL-13"/>
 <result pre="play a critical role in causing allergic symptoms in atopic" exact="dermatitis" post="and allergic asthma ( 18 ). In particular, IL-13"/>
 <result pre="critical role in causing allergic symptoms in atopic dermatitis and" exact="allergic asthma" post="( 18 ). In particular, IL-13 is known to"/>
 <result pre="role in causing allergic symptoms in atopic dermatitis and allergic" exact="asthma" post="( 18 ). In particular, IL-13 is known to"/>
 <result pre="of ILC2s have been reported in hypersensitivity-related skin inflammation, including" exact="atopic dermatitis," post="little is known about the regulation of ILC2s in"/>
 <result pre="G and H). In some allergic diseases, such as casein-induced" exact="food allergy," post="the inhibitory effect of IL-10 + B reg cells"/>
 <result pre="dermal MCs contributes to the anti-inflammatory effects of MCs in" exact="allergic contact dermatitis" post="( 14 ). It was also reported that MC-derived"/>
 <result pre="MCs contributes to the anti-inflammatory effects of MCs in allergic" exact="contact dermatitis" post="( 14 ). It was also reported that MC-derived"/>
 <result pre="contributes to the anti-inflammatory effects of MCs in allergic contact" exact="dermatitis" post="( 14 ). It was also reported that MC-derived"/>
 <result pre="It was also reported that MC-derived IL-2 contributes to the" exact="suppression" post="of chronic allergic skin inflammation via the induction of"/>
 <result pre="expansion and differentiation of IL-10 + B reg cells in" exact="colitis" post="( 10 ) and IgE-mediated anaphylaxis ( 9 )."/>
 <result pre="a type of effector cell in skin inflammatory disorders, including" exact="atopic dermatitis" post="( 19 , 24 ). In our study, the"/>
 <result pre="type of effector cell in skin inflammatory disorders, including atopic" exact="dermatitis" post="( 19 , 24 ). In our study, the"/>
 <result pre="not PeC, by MCs plays a critical role in the" exact="suppression" post="of the CHS response ( Fig. 4E). Notably, the"/>
 <result pre="of IL-10 + B reg cells in IgE-mediated anaphylaxis and" exact="colitis" post="through the interaction of CD40 (on B cells) and"/>
 <result pre="cells) and CD40L (MCs) unlike that in IgE-mediated anaphylaxis or" exact="colitis" post="(fig. S7). We next measured changes in typical T"/>
 <result pre="reported to be critical effector cells in skin inflammation, including" exact="atopic dermatitis" post="( 19 , 24 ). We also observed that"/>
 <result pre="to be critical effector cells in skin inflammation, including atopic" exact="dermatitis" post="( 19 , 24 ). We also observed that"/>
 <result pre="IL-10 + B reg cell population and the subsequent reduced" exact="suppression" post="of IL-13 + ILC2s. We further observed that the"/>
 <result pre="in the spleen and LNs to suppress skin inflammation via" exact="suppression" post="of IL-13 + ILC2s. B reg cells have been"/>
 <result pre="ILC2s, and IL-10 + B reg cells during OXZ-induced chronic" exact="atopic dermatitis" post="(AD)–like skin inflammation. Fig. S4. Comparison of MCs and"/>
 <result pre="and IL-10 + B reg cells during OXZ-induced chronic atopic" exact="dermatitis" post="(AD)–like skin inflammation. Fig. S4. Comparison of MCs and"/>
 <result pre="Fig. S7. CD40L on MCs is not critical for the" exact="suppression" post="of CHS. Fig. S8. Amounts of T H1 and"/>
 <result pre="I. , Parker D. , Turk J. L. , B-cell" exact="suppression" post="of delayed hypersensitivity reactions. Nature 251, 550– 551 ("/>
 <result pre="D. , Turk J. L. , B-cell suppression of delayed" exact="hypersensitivity" post="reactions. Nature 251, 550– 551 ( 1974). 4547522 3"/>
 <result pre="K. , Update of immune events in the murine contact" exact="hypersensitivity" post="model: Toward the understanding of allergic contact dermatitis ."/>
 <result pre="in the murine contact hypersensitivity model: Toward the understanding of" exact="allergic contact dermatitis" post=". J. Invest. Dermatol. 133, 303– 315 ( 2013)."/>
 <result pre="the murine contact hypersensitivity model: Toward the understanding of allergic" exact="contact dermatitis" post=". J. Invest. Dermatol. 133, 303– 315 ( 2013)."/>
 <result pre="murine contact hypersensitivity model: Toward the understanding of allergic contact" exact="dermatitis" post=". J. Invest. Dermatol. 133, 303– 315 ( 2013)."/>
 <result pre="A. D. , Haase C. , Immunological mechanisms of contact" exact="hypersensitivity" post="in mice. APMIS 120, 1– 27 ( 2012). 22151305"/>
 <result pre="J. , Mast cell-derived interleukin 10 limits skin pathology in" exact="contact dermatitis" post="and chronic irradiation with ultraviolet B . Nat. Immunol."/>
 <result pre=", Mast cell-derived interleukin 10 limits skin pathology in contact" exact="dermatitis" post="and chronic irradiation with ultraviolet B . Nat. Immunol."/>
 <result pre=", Rivera J. , Mast cell interleukin-2 production contributes to" exact="suppression" post="of chronic allergic dermatitis . Immunity 35, 562– 571"/>
 <result pre="Mast cell interleukin-2 production contributes to suppression of chronic allergic" exact="dermatitis" post=". Immunity 35, 562– 571 ( 2011). 21982597 16"/>
 <result pre="Maurer M. , Mast cells limit the exacerbation of chronic" exact="allergic contact dermatitis" post="in response to repeated allergen exposure . J. Immunol."/>
 <result pre="M. , Mast cells limit the exacerbation of chronic allergic" exact="contact dermatitis" post="in response to repeated allergen exposure . J. Immunol."/>
 <result pre=", Mast cells limit the exacerbation of chronic allergic contact" exact="dermatitis" post="in response to repeated allergen exposure . J. Immunol."/>
 <result pre=", Palm N. W. , Flavell R. A. , TH2," exact="allergy" post="and group 2 innate lymphoid cells. Nat. Immunol. 14,"/>
 <result pre="Weninger W. , Dermal group 2 innate lymphoid cells in" exact="atopic dermatitis" post="and allergy. Curr. Opin. Immunol. 31, 108– 114 ("/>
 <result pre="W. , Dermal group 2 innate lymphoid cells in atopic" exact="dermatitis" post="and allergy. Curr. Opin. Immunol. 31, 108– 114 ("/>
 <result pre="Roers A. , Mast cells are key promoters of contact" exact="allergy" post="that mediate the adjuvant effects of haptens . Immunity"/>
</results>
